Hormone Replacement Technologies

Hormone Replacement Technologies, Inc. (HRT, Inc.) is a specialty pharmaceutical company and a subsidiary of Transdermal Delivery Solutions Corp. (TDSC). The company focuses on developing and commercializing innovative hormone replacement therapies using a proprietary, patchless, spray-on transdermal delivery system. Its lead product candidate, Testagen (also known as Testagen TDS or HypoSpray), is a topical testosterone replacement therapy designed to treat male hypogonadism with improved absorption and reduced risk of accidental transference compared to traditional gels. HRT, Inc. aims to address unmet needs in the hormone replacement market by providing safer and more convenient delivery options for both men and women. The company has advanced its lead program into pivotal clinical trials in both the United States and the United Kingdom.